Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease
More than 60-80% of dementia cases worldwide in elderly people is caused by Alzheimer’s disease (AD) (Alzheimer’s disease Facts and Figures, 2017). Histopathologically, AD is characterized by the aggregation of extracellular neuritic β-amyloid peptide that leads to the creation of senile plaques, and the production of intracellular neurofibrillary tangles caused by tau protein hyperphosphorylation (Braak et al., 1988; Merz et al., 1983).